BlackRock, Inc. has officially notified that its direct and indirect ownership in Orion Oyj, a Finnish pharmaceutical company, has exceeded the 5% threshold as of June 4, 2026. This includes shares held directly, indirectly, and through financial instruments, totaling just over 5% of Orion's shares. The disclosure is made under Finnish securities law, signaling BlackRock's increased stake in Orion, which could influence investor confidence and company governance. Orion is known for its development and marketing of human and veterinary medicines, with a strong focus on cancer and pain therapies.
Van Eck Associates Corporation notified a decrease in its voting rights in Endeavour Mining PLC to 6.947% as of June 19, 2026, down from a previous 7.995%. The reduction reflects changes in holdings across various Van Eck ETFs focused on gold miners ...
The Sanofi Foundation has announced a renewed focus on supporting children and young people, especially those with serious illnesses. It plans to invest €15 million annually in programs that improve early diagnosis, care, and social inclusion, partne...
The Sanofi Foundation is enhancing its focus on supporting children and young people, especially those with serious illnesses, by allocating an annual budget of €15 million. The foundation partners with NGOs and healthcare groups to improve early dia...
Japan's government has allocated $660 million in subsidies to accelerate the development and supply chain of all-solid-state batteries (ASSBs), aiming for commercialization by 2030. This support is part of the Battery Stable Supply Assurance Plan, fo...
Ethereum (ETH) is trading near $1,615, down over 3%, with bearish momentum and selling pressure capping rallies above $1,700. Historical support at around $1,150 suggests a potential 30% further decline if current resistance holds. Meanwhile, US spot...
